TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+10.67%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$735M
AUM Growth
–
Cap. Flow
+$735M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
55.66%
Holding
60
New
60
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$77.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$62.9M |
| 3 |
CELG
Celgene Corp
CELG
|
$59.6M |
| 4 |
Biogen
BIIB
|
$41.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$36.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 84.4% |
| 2 | Financials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $77.1M | 10.48% | +1,504,712 | New | +$77.1M |
|
|
2
Regeneron Pharmaceuticals
REGN
$61.5B
| $62.9M | 8.56% | +279,759 | New | +$62.9M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $59.6M | 8.11% | +510,046 | New | +$59.6M |
|
|
4
Biogen
BIIB
$19.4B
| $41.3M | 5.62% | +191,983 | New | +$41.3M |
|
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $36.3M | 4.93% | +454,164 | New | +$36.3M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $34.3M | 4.66% | +371,329 | New | +$34.3M |
|
7
Puma Biotechnology
PBYI
$254M
| $31.6M | 4.29% | +711,800 | New | +$31.6M |
|
8
Perrigo
PRGO
$3.27B
| $24.5M | 3.33% | +202,607 | New | +$24.5M |
|
|
ONXX
9
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $22M | 3% | +253,856 | New | +$22M |
|
10
Amgen
AMGN
$155B
| $19.7M | 2.69% | +200,143 | New | +$19.7M |
|
|
WCRX
11
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
| $15.6M | 2.12% | +782,797 | New | +$15.6M |
|
12
Viatris
VTRS
$12.3B
| $15.1M | 2.06% | +488,209 | New | +$15.1M |
|
|
SHPG
13
DELISTED
Shire pic
SHPG
| $14.7M | 1.99% | +154,153 | New | +$14.7M |
|
14
Merck
MRK
$210B
| $13.8M | 1.87% | +296,620 | New | +$13.8M |
|
|
CBST
15
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $12.8M | 1.75% | +265,972 | New | +$12.8M |
|
|
AKRX
16
DELISTED
Akorn, Inc.
AKRX
| $12.7M | 1.72% | +935,758 | New | +$12.7M |
|
|
AET
17
DELISTED
Aetna Inc
AET
| $12.5M | 1.7% | +197,241 | New | +$12.5M |
|
18
Verastem
VSTM
$569M
| $12.3M | 1.67% | +884,920 | New | +$12.3M |
|
19
Teva Pharmaceuticals
TEVA
$21.1B
| $12.2M | 1.66% | +311,476 | New | +$12.2M |
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $11.5M | 1.57% | +91,500 | New | +$11.5M |
|
21
Hologic
HOLX
$14.9B
| $11.4M | 1.56% | +592,915 | New | +$11.4M |
|
|
MDVN
22
DELISTED
MEDIVATION, INC.
MDVN
| $10.2M | 1.38% | +206,439 | New | +$10.2M |
|
23
Neurocrine Biosciences
NBIX
$13.8B
| $9.47M | 1.29% | +707,990 | New | +$9.47M |
|
24
Incyte
INCY
$16.5B
| $9.27M | 1.26% | +421,300 | New | +$9.27M |
|
|
QCOR
25
DELISTED
QUESTCOR PHARMA INC
QCOR
| $7.91M | 1.08% | +173,928 | New | +$7.91M |
|